Who
Ram Aiyar
President and CEO
Company insider
Files Form 4 as: President and CEO, Korro Bio.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $519K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Nov 2023
- Last trade
- 4 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Aug 2026filed 5 Aug 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $63K5,802 at $10.84 | filing |
| 4 Aug 2026filed 5 Aug 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $63K5,802 at $10.84 | filing |
| 29 May 2026filed 2 Jun 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $197K15,152 at $12.98 | filing |
| 29 May 2026filed 2 Jun 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $197K15,152 at $12.98 | filing |
| 26 May 2026filed 28 May 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | $617K50,000 at $12.33 | filing |
| 26 May 2026filed 28 May 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | $617K50,000 at $12.33 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 3 Feb 2025filed 5 Feb 2025 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 3 Nov 2023filed 7 Nov 2023 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —136,234 | filing |
| 3 Nov 2023filed 7 Nov 2023 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —36,769 | filing |
| 3 Nov 2023filed 7 Nov 2023 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —30,130 | filing |
| 3 Nov 2023filed 7 Nov 2023 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —156,760 at $0.00 | filing |
| 3 Nov 2023filed 7 Nov 2023 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —4,613 | filing |
News
BioLineRx (NASDAQ:BLRX) and Korro Bio (NASDAQ:KRRO) Head to Head SurveyKRRO · dailypolitical.com · 14 Oct 2026Contrasting BioLineRx (NASDAQ:BLRX) & Korro Bio (NASDAQ:KRRO)KRRO · tickerreport.com · 14 Oct 2026Korro Bio Doses First Cohort In Phase 1/2 Study Of KRRO-121 For HyperammonemiaKRRO · rttnews.com · 7 Oct 2026
0 headlines in the last 90 days name Ram Aiyar; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.